Showing results (21-30 of 1,231) with videos related to
Sort By:
Pageof 124
Brain Research Bulletin|September 7, 2000
Why move the eyes if we can move the head?J M Delgado-GarcíaMicrobes and Infection|March 17, 2001
Inhibitory neuropeptide receptors on macrophagesD Ganea, M DelgadoArchivum Immunologiae Et Therapiae Experimentalis|May 12, 2001
Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAPD Ganea, M DelgadoJournal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3M Delgado, D GaneaJournal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expressionM Delgado, D GaneaJournal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivoM Delgado, D GaneaArchives of Physiology and Biochemistry|April 6, 2002
VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibiting peripheral deletion of antigen-specific effectorsM Delgado, D GaneaArchives of Physiology and Biochemistry|April 6, 2002
Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivoM Delgado, D GaneaJournal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expressionM Delgado, D GaneaPageof 124